Global Hormonal Contraceptives Market
Hormonal Contraceptives Market

Report ID: SQMIG35I2363

sales@skyquestt.com
USA +1 351-333-4748

Hormonal Contraceptives Market Size, Share, and Growth Analysis

Global Hormonal Contraceptives Market

Hormonal Contraceptives Market Size, Share & Trends Analysis Report, By Product (Oral Contraceptives, Contraceptive Patch, Implantable rod, Vaginal Ring, Intrauterine device (IUD), Injectables Birth Control, & Emergency Contraceptive pills), By Route of Administration (Orally, Transdermal, Intravaginal, Subdermal, & Others), By Hormone (Combined Hormone, & Progestin Only), By Age Group (18–25 years, 26–35 years, & Above 36+), By End User (Household, Hospital , Clinics), By Region - Industry Forecast, 2026-2033


Report ID: SQMIG35I2363 | Region: Global | Published Date: May, 2025
Pages: 194 |Tables: 149 |Figures: 79

Format - word format excel data power point presentation

Hormonal Contraceptives Market Insights

Global Hormonal Contraceptives Market size was valued at USD 17.84 Billion in 2024 and is poised to grow from USD 18.6 Billion in 2025 to USD 26.05 Billion by 2033, growing at a CAGR of 4.3% in the forecast period (2026–2033).

The surge in demand for effective birth control, high usage rate of hormonal contraceptive among women, increase in awareness of reproductive health and expanded access through private and public healthcare systems drive the growth of the market. According to KFF organization, it was reported that around 82% women of reproductive age use some form of contraceptive in one year. In addition, almost half of contraceptive users used more than one contraceptive methods. Nearly 85% of women use contraceptive method in order to prevent pregnancy and 14% use it for another reason such as managing a medical condition, or preventing sexual transmitted infection.

In addition, the increasing accessibility initiatives program drives the growth of the market. The nonprofit Contraceptive Access Initiative (CAI) started in 2020, aims to support affordable over-the-counter access to the combined hormonal contraceptive pill and the progestin-only pill (mini-pill) without age restrictions. Furthermore, The National Family Planning Program in India, provide free access to hormonal contraceptives through public health system. These initiatives surge the demand for hormonal contraceptive and rive the growth of the market.

Furthermore, the ongoing funding efforts surge the growth of the market. In February 2025, Pharmac, a pharmaceutical management agency, is consulting on funding a new progestogen-only oral contraceptive pill known as desogestrel. A wide range of oral contraceptive pills are avaible in New Zealand and funding desogestrel would provide consumers with another option to prevent pregnancy.

How is AI transforming the hormonal contraceptive industry?

Artificial Intelligence is transforming the hormonal contraceptive industry by enhancing customer experiences, increase in advancement in product development and optimizing the healthcare services. AI-powered algorithms enable the creation of personalized contraceptives solution by identifying individual health data such as lifestyle, hormonal levels, and medical history, in order to recommend the most effective contraceptive methods. This enhances the patient satisfaction and improve efficacy.

In addition, AI is advancing the R&D process which allow faster identification of potential contraceptive compound. This will also reduce the time to market for new products. Furthermore, AI -driven chatbots and virtual assistants offer real-time information, which helps the users with queries related to various type of contraceptives, its side effect and usage guidance.

Moreover, AI also aids in predictive analytics which help the healthcare providers to track usage patterns and offer timely interventions. Thus, the integration of AI in hormonal contraceptive industry foster innovation, efficiency and more personalized care, which enhance user experience and market offering.

Market snapshot - 2026-2033

Global Market Size

USD 17.1 Billion

Largest Segment

Oral Contraceptives

Fastest Growth

Oral Contraceptives

Growth Rate

4.3% CAGR

Hormonal Contraceptives Market 2026-2033 ($ Bn)
Country Share for Asia Pacific Region 2025 (%)

To get more insights on this market click here to Request a Free Sample Report

Hormonal Contraceptives Market Segments Analysis

Global Hormonal Contraceptives Market is segmented by Product, By Route of Administration, By Hormone, By Age Group, By End User and region. Based on By Product, the market is segmented into Oral Contraceptives, Contraceptive Patch, Implantable rod, Vaginal Ring, Intrauterine device (IUD), Injectables Birth Control and Emergency Contraceptive pills. Based on By Route of Administration, the market is segmented into Orally, Transdermal, Intravaginal, Subdermal and others. Based on By Hormone, the market is segmented into Combined Hormone and Progestin Only. Based on By Age Group, the market is segmented into 18–25 years, 26–35 years and Above 36+. Based on By End User, the market is segmented into Household, Hospital and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

How is the oral segment shaping contraceptive market growth?

As per the 2024 global Hormonal Contraceptives Market analysis, the oral contraceptive segment led the market by holding the largest share. The segment's leadership is due to the high effectiveness of oral pills in preventing pregnancy, their widespread availability and their affordability, across both developing and developed regions. The oral contraceptives are easy to use, offer greater autonomy, non-invasive in nature compare to other hormonal contraceptives methods. In addition, the oral contraceptives are also prescribed for various other health benefits such as managing acne, regulating menstrual cycles and treating hormonal imbalance. These factor drives the growth of the market.

Why is contraceptive use rising among 26–35 age group?

Based on the 2024 global Hormonal Contraceptives Market forecast, the 26 – 35-year age group category is expected to grow at the highest rate. This growth is driven by rising tendency among individual to delay parenthood in favor of personal goals and career. The hormonal contraceptive offer an effective and convenient ways in order to manage the fertility. In addition, the increase awareness of reproductive health, higher level of education and better access to healthcare services contributes to the growth of this segment.

Global Hormonal Contraceptives Market Analysis by Product ($ Bn) 2026-2033

To get detailed segments analysis, Request a Free Sample Report

Hormonal Contraceptives Market Regional Insights

Why is Asia Pacific Leading Hormonal Contraceptives Market in 2024?

In 2024, Asia Pacific dominates the hormonal contraceptives market owing to its large reproductive age population, surge in government initiatives which support reproductive health and rise in awareness of family planning. Countries like China and India are witnessing increasing adoption due to advancement in healthcare infrastructure, and availability of contraceptive products to consumers through private and public channels. The increasing female workforce participation and urbanization propel the growth of the market.

Japan Hormonal Contraceptives Market

The initiatives taken by government around reproductive health surge the demand for hormonal contraceptive and drive the Japan market. Based on SkyQuest analysis, around 20% of women use oral contraceptive pills in Japan in 2023.

​In November 2023, the Ministry of Health, Labour and Welfare initiated a pilot program initiated a pilot program which allow 145 pharmacies worldwide to sell emergency contraceptive pills without prescription. This enhance the accessibility of pills among consumer.

India Hormonal Contraceptives Market

The rise in consumer adoption of family planning and increase in government initiative for reproductive health surge the growth of India hormonal contraceptive market. According to Ministry of Health and Family Welfare, it was reported that there is increase in ‘demand satisfied’ for family planning from 66% to 76% among women aged 15 to 49 years. This improves the accessibility of product. There is also increase in Contraceptive Prevalence Rate from 54% to 67%.

In addition, various government initiatives such as Mission Parivar Vikas and the facts that around 68% of modern methods user’s access contraceptives from public healthcare facilities. This ensure that the contraceptive such as IUD, and injectable are widely available and affordable.

Why is Demand for Hormonal Contraceptive Products Fueling Growth in North America?

The widespread insurance coverage, rise in awareness and strong advocacy for reproductive rights drive the growth of North America Hormonal Contraceptive Market. The U.S. Affordable care act mandates coverage for FDA-approved contraceptives without cost sharing which enhance the accessibility. In addition, the high female workforce participation in U.S, and a preference for long-term methods such as implant and hormonal surge the demand for hormonal contraceptive in North America.

Furthermore, the shift in societal norms which support delayed parenthood and improved education on family planning drive the growth of the market.

U.S. Hormonal Contraceptives Market

In North America, the United States led the Hormonal Contraceptives Market due to increase in use of hormonal contraceptive among consumer and policy supports. According to CDC, from 2022 to 2023, around 37% of women aged 15 to 49 years receive the family planning services with 10.4% using long-acting reversible contraceptive pills such as implants and IUDs, and 14% using oral contraceptives. In addition, in 2023, the Title X clinics offer around 3 million contraceptives services visits which is around 14% increase from 2020. Furthermore, in 2024, the Biden-Harris administration proposed to expand the Affordable care act policy to covers OTC contraceptives. These factors increase the affordability and accessibility which drive the growth of the market.

Canada Hormonal Contraceptives Market

Canada in North America is expanding immensely in the Hormonal Contraceptives Market because of various policy initiatives by government. The government of Canada introduced legislation in order to offer universal single-payer access to select contraceptives. This enhances reproductive autonomy for around 9 million Canadian of reproductive age. These efforts are mostly significant for younger women with 90% of those aged between 15 to 24 reporting the use of contraceptives. Such policy are reducing financial barrier and promote equitable access to reproductive health services across the country.

How is Europe Maintaining its Dominance in Hormonal Contraceptives Market Industry?

Europe held dominance in the past and is likely to continue so during the forecast period. High meat consumption in the region, particularly in countries like Germany, France, and Spain, is driving demand for novel processing technologies. Sustainability initiatives and food safety policies are encouraging automation and energy-efficient equipment adoption. Increased demand for processed meat products, including sausages, cold cuts, and ready-to-eat meals, is also fueling market growth in the region.

Germany Hormonal Contraceptives Market

Germany is one of the largest European markets for Hormonal Contraceptives Market because of its societal attitudes and preference. The increase in use of modern contraceptive methods among women also drive the growth of the market. According to our analysis Germany possess the highest prevalence of modern contraceptive use. In addition, the government of Germany has implemented policies in order to enhance various access to contraception. The “biko” model projects allows the women with limited financial mean to receive contraception at no cost at any of the location in Germany. These factors drive the growth of the market in Germany.

Spain Hormonal Contraceptives Market

Spain's hormonal contraceptive market is experiencing growth, driven by progressive policies and demographic trends. In 2022, the Spanish government reformed the Organic Law 2/2010 on Sexual and Reproductive Health and Voluntary Termination of Pregnancy, introducing measures to enhance sexuality education, menstrual health, and access to contraception. This reform aims to improve reproductive rights and access to reproductive health services.​

Global Hormonal Contraceptives Market By Geography, 2026-2033
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Hormonal Contraceptives Market Dynamics

Hormonal Contraceptives Market Drivers

Increasing Awareness about family planning and women’s education

  • The increase in awareness about family planning, coupled with rising female education levels are one of the key factors for the growth of the market. The Family Planning 2030 (FP2030) aims to enable nearly 120 million women and girls to access modern contraceptive in middle- and low-income countries. As of 2023, nearly 370 million women were using modern contraceptive, with hormonal methods, such as injectables and orals pills, globally.

Rise in government-led initiatives promoting birth control

  • The surge in initiative by government to promote birth control act as a major driving factor for the growth of the market. Governments are recognizing family planning as a critical public health and socio-economic development tool, globally. According to the United Nations Population Fund (UNFPA), 923 million women of reproductive age (15–49 years) worldwide were using some form of contraception as of 2023, with hormonal methods accounting for over 27% of usage.

Hormonal Contraceptives Market Restraints

Social Resistance and Cultural Stigma

  • In various region such as Middle East, South Asia, and part of Sub-Saharan African, religious conservatism, deep-routed cultural norma and patriarchal structure discourage the use of hormonal contraceptives. Mosty unmarried women and adolescents face stigma and community judgement which limit the access to seek reproductive care and hinder the growth of the market.

Side effect, various health related issue and misinformation about hormonal contraceptive

  • The side effect associated with the use of hormonal contraceptive hinder the growth of the market. The side effect ranges from mood swings to various serious risk such as blood clot. In addition, the spreading of misinformation in social media restrain the market growth.

Request Free Customization of this report to help us to meet your business objectives.

Hormonal Contraceptives Market Competitive Landscape

To remain competitive in the Hormonal Contraceptives Market, major manufacturers focus on regulatory compliance, product innovation, and expanding access through partnership. The key payers invest in research & development in order to develop advanced formulations such as long-acting injectables which increase production processes to meet the regulatory standard. Acquisition and mergers also drive the market expansion. With the increasing demand for non-oral options among consumers, various companies are diversifying their product portfolio and enhancing their sustainability efforts.

Top Player’s Company Profiles

  • AbbVie
  • Bayer
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V. (Viatris Inc.)
  • Allergan plc
  • Johnson & Johnson
  • Agile Therapeutics
  • Organon Group
  • Afaxys, Inc.
  • HRA Pharma
  • Piramal Enterprises Ltd.
  • Novartis AG
  • GlaxoSmithKline plc
  • Dr. Reddy's Laboratories Ltd.
  • Cupid Limited
  • Lupin Pharmaceuticals, Inc.
  • Theramex
  • Evotec SE
  •  

Recent Developments in Hormonal Contraceptives Market

  • In March 2025, NEXT Life Sciences, the modern reproductive healthcare company, announced the announced the beginning of Male contraceptive clinical trial in Australia. This launch of Plan A clinical trail takes the NEXT life science contraceptive solution from pre-clinical stage to clinical stage.  The initiation of clinical trials in Australia represents a significant advancement in male contraceptive development.
  • In August 2024, Perrigo Company Plc., one of the leading provider of Consumer self-product company, announced that Opill, a birth control pill partner with Women’s National Basketball Association (WNBA). The partnership focus on building strength, health equity and confidence
  • In January 2025, Lupin, a pharmaceutical company, announced the launch of Minozoya in various dosage in United States. This product also receive approval from the US FDA. This product is used by females in order to prevent pregnancy.

Hormonal Contraceptives Key Market Trends

Hormonal Contraceptives Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected using Primary Exploratory Research backed by robust Secondary Desk research. 

As per SkyQuest analysis, the global Hormonal Contraceptives market is driven by rising awareness around reproductive health, increase in use of contraceptive method among women, and increase in initiative taken by government of various region around reproductive healthcare. In addition, advancement in technology is reshaping user preference and supporting long term market growth.

In addition, the policy driven shift which include government-led family planning programs and inclusion of various contraceptives in insurance schemes surge the demand across both rural and urban areas.

The leading key players are also actively investing in advanced formulations and education outreach in order to expand their consumer base. Asia pacific, Latin America and some parts of Sub-Saharan Africa present robust growth opportunity driven by supportive policy environment and expanding healthcare infrastructure. These factors collectively signal a positive long-term outlook for hormonal contraceptive landscape.

Report Metric Details
Market size value in 2024 USD 17.84 Billion
Market size value in 2033 USD 26.05 Billion
Growth Rate 4.3%
Base year 2024
Forecast period 2026-2033
Forecast Unit (Value) USD Billion
Segments covered
  • By Product
    • Oral Contraceptives, Contraceptive Patch, Implantable rod, Vaginal Ring, Intrauterine device (IUD), Injectables Birth Control, Emergency Contraceptive pills
  • By Route of Administration
    • Orally, Transdermal, Intravaginal, Subdermal, others
  • By Hormone
    • Combined Hormone, Progestin Only
  • By Age Group
    • 18–25 years, 26–35 years, Above 36+
  • By End User
    • Household, Hospital, Clinics
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • AbbVie
  • Bayer
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V. (Viatris Inc.)
  • Allergan plc
  • Johnson & Johnson
  • Agile Therapeutics
  • Organon Group
  • Afaxys, Inc.
  • HRA Pharma
  • Piramal Enterprises Ltd.
  • Novartis AG
  • GlaxoSmithKline plc
  • Dr. Reddy's Laboratories Ltd.
  • Cupid Limited
  • Lupin Pharmaceuticals, Inc.
  • Theramex
  • Evotec SE
  •  
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

 

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Hormonal Contraceptives Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Hormonal Contraceptives Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Hormonal Contraceptives Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Hormonal Contraceptives Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Hormonal Contraceptives Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Hormonal Contraceptives Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

Hormonal Contraceptives Market Report Snapshots

$5,300

REQUEST FOR SAMPLE

Please verify that you're not a robot to proceed!
Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Hormonal Contraceptives Market size was valued at USD 17.84 Billion in 2024 and is poised to grow from USD 18.6 Billion in 2025 to USD 26.05 Billion by 2033, growing at a CAGR of 4.3% in the forecast period (2026–2033).

To remain competitive in the Hormonal Contraceptives Market, major manufacturers focus on regulatory compliance, product innovation, and expanding access through partnership. The key payers invest in research & development in order to develop advanced formulations such as long-acting injectables which increase production processes to meet the regulatory standard. Acquisition and mergers also drive the market expansion. With the increasing demand for non-oral options among consumers, various companies are diversifying their product portfolio and enhancing their sustainability efforts. 'AbbVie', 'Bayer', 'Pfizer Inc.', 'Merck & Co., Inc.', 'Teva Pharmaceutical Industries Ltd.', 'Mylan N.V. (Viatris Inc.)', 'Allergan plc', 'Johnson & Johnson', 'Agile Therapeutics', 'Organon Group', 'Afaxys, Inc.', 'HRA Pharma', 'Piramal Enterprises Ltd.', 'Novartis AG', 'GlaxoSmithKline plc', 'Dr. Reddy's Laboratories Ltd.', 'Cupid Limited', 'Lupin Pharmaceuticals, Inc.', 'Theramex', 'Evotec SE', ' '

The increase in awareness about family planning, coupled with rising female education levels are one of the key factors for the growth of the market. The Family Planning 2030 (FP2030) aims to enable nearly 120 million women and girls to access modern contraceptive in middle- and low-income countries. As of 2023, nearly 370 million women were using modern contraceptive, with hormonal methods, such as injectables and orals pills, globally.

Short-Term: The rapid digital transformation in contraceptive industry with the launch of various app-based prescription services and telemedicine is making hormonal contraceptive user friendly. The increasing demand for convenience and privacy mostly among millennial and Gen Z, the healthcare providers are adopting digital platforms for prescription management, compliance tracking and improve consultancy. These developments are increasing the adherence rate and user satisfaction.

In 2024, Asia Pacific dominates the hormonal contraceptives market owing to its large reproductive age population, surge in government initiatives which support reproductive health and rise in awareness of family planning. Countries like China and India are witnessing increasing adoption due to advancement in healthcare infrastructure, and availability of contraceptive products to consumers through private and public channels. The increasing female workforce participation and urbanization propel the growth of the market.
AGC3x.webp
Aisin3x.webp
ASKA P Co. LTD3x.webp
BD3x.webp
BILL & MELIDA3x.webp
BOSCH3x.webp
CHUNGHWA TELECOM3x.webp
DAIKIN3x.webp
DEPARTMENT OF SCIENCE & TECHNOLOGY3x.webp
ETRI3x.webp
Fiti Testing3x.webp
GERRESHEIMER3x.webp
HENKEL3x.webp
HITACHI3x.webp
HOLISTIC MEDICAL CENTRE3x.webp
Institute for information industry3x.webp
JAXA3x.webp
JTI3x.webp
Khidi3x.webp
METHOD.3x.webp
Missul E&S3x.webp
MITSUBISHI3x.webp
MIZUHO3x.webp
NEC3x.webp
Nippon steel3x.webp
NOVARTIS3x.webp
Nttdata3x.webp
OSSTEM3x.webp
PALL3x.webp
Panasonic3x.webp
RECKITT3x.webp
Rohm3x.webp
RR KABEL3x.webp
SAMSUNG ELECTRONICS3x.webp
SEKISUI3x.webp
Sensata3x.webp
SENSEAIR3x.webp
Soft Bank Group3x.webp
SYSMEX3x.webp
TERUMO3x.webp
TOYOTA3x.webp
UNDP3x.webp
Unilever3x.webp
YAMAHA3x.webp
Yokogawa3x.webp

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Feedback From Our Clients